INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140497, 19059, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', NULL, NULL, NULL, X'789c5590416ec4200c45aff20f309a4577bdc7ecaa2e5ce2044b801176d2e6f6351369d42e4042fa7e7e9f4766b47d98b4ed062a457841662a9ee3d91648731e7de8ca66a28d0a9ca946a474546de23ae0c1e8e4c2cd0d5f1c28f00f5569c1d2062be22854bbddaeb93f797c8b6704bff34057138f2513307727adab0ebf442a854a1c2c9c74ec15cb3e6670c2ae6d3467ef78643ea389e97fc997e0fa7c046852ed34e72a09265b33d89e32c87090e9415bb4b5b3a5907b86e95059ae7629be23b4e3de07cf9253e355f48e8fb7f7cf5fb7b88087', NULL, NULL, NULL, 'NCBI', 1768173735, 1768173735, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140498, 19071, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768173737, 1768173737, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140499, 19071, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768173740, 1768173740, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140500, 19131, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'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', X'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', X'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', NULL, 'NCBI', 1768173742, 1768173742, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140501, 19135, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'789c7552cb6e1b310cfc157ec0d680ed1e72755304280a140572088ac007ee8af612d68a0229f9f137fd967e59a9789da6afe3ee88c399e13c44ee31192927a846c00683a4a2c829f08085029cb88c604525ed41142609a40ec0fdb7afebcd7be03472cf45d40053809132161e80a78cac13a502a11214813292a3bc1f0b25a755b603c80eec9206c9741dbe6471d458d2029e97eb2d3cdf6de17392536a18a935b0f091cba551eedea877695c0ce83c70665f6bcd0b46933f0d7557474a59b4f953c2a1f8461f4843ac81dd2726cce325e299adf38f3d0b059ab083ac55b9d497bf01aaba5554c6053cf25463c14452dbda414689b7449314c0df65f83ee86b69e8e891c49758e6ac117a39c3093535296ead25175dba1578f8b8798739ab1cfd75c49ea2bf59c0071f78ba0e186ce6ed364a8d017acff6281c667ae75b81237e2f4fbf5adbf126c70ec8320d8c315e8077b06cc1ae7e7c0f8e1d5c2c1ec91929353b56270a0bf8b483f5b5194af0df77dd6b2abf74d98173765d7ecac9cfba6fb56a666fddb8fff20881b292cd95582db7b009815b7e186f19dd2e47ff6a5fbb53e3741d43556dbfda599cfdb5c9be7eeef75f9d5efc041ba125b2', X'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', X'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', NULL, X'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', X'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', X'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', NULL, 'NCBI', 1768173745, 1768173745, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140502, 19152, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768173747, 1768173747, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140503, 19161, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'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', X'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', X'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', NULL, 'NCBI', 1768173749, 1768173749, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140504, 19184, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'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', X'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', X'789c6553cb6e143110fc95fe8065d94459e51c11210e200e89c40171e8d83d33adf831b23db319be866fe1cba8f6262488cb3c3c76557555cd9d8ea912274f775b9c5b8e95f2405f57293e57a10f3c0ca249c8e554176cd09c482b8d92a470081b1519b978f1c4952a0fb2a71befb5e98a332f873551ccb5515d1e6ae3e4a492cfb8a4dc28095eab366e421f6f6f88e7b9e49583e1859c46bbbf252f125921f9a46d02ae5152905502e89bce4b0090a7878dda2458e1b634d3446d9bd501b68f85115fc561fc921738707da096e9e270a038d22c857cd1f4b8a76f930631bcd277a70c112ec728c9e6f6acb0015ee4938d46432e7fc1779dae5bbacc067ed5c1dfc32d6079910880b36bdf8f573fe81e9ae5895da3cfb7c743879a96c81877e5a2720e2a701905945e6628003812495e57f50be6ab92aad9af6d33c217257bfa944fb0a9ecba3102af6277aa1361aa076927914417c7c3ef5f46737996fa38eed102785664cea5d5cee52cad36717b9eaf6775b2dbf1fa7c88265eed4c5d82b120a9811b072893dae3c84feafe0b6347a7ee72452b75004d6ac41eaab14db0c581bf2e6e32a6c66eda1cbaa7bc839d65dada14fb33180b38910fe2476776ddb62afa7381208abc51766e811598fbd509b8f5202f5db8d85f1226bf7fe3558f9129e820efda54044b4951d0ff1a55388de841c91165ea95ba32ac2f9c781453f5cf2f6614cdd0fa178b3c6a30c7462346f3692ee02fd6324d6b0eab9809b3a571fecbcadb74e1b4e3e7cec56c5edabad01f69456592', NULL, 'NCBI', 1768173752, 1768173752, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140505, 19193, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'789c4d534b8ed43010bd4a69d64d034282f5088406891d880d6251b12b7169fc09fea495dbcc59e6643c3bd3f46ca2d8aa57f53ee5fb8dd5f3e485bea4c28bd0d79443218e967ed42c71a9aed0679e67d128a485d25459e340cc3905da386b6a854a6ad948399146e39bd5b8904980094dc211f7860da7ebe13179a6d82a7eab3079e1ad6377c91353e02aa741a13aa1a571e6c840e6bc9fe95b24b656aba6d87bde889914428a7ea7393540b98b7829dd5010c1d0f2a14ca2e465279b353e425106369616c4f6b2355dace47e5bbbca8a7e399ce9f7a73f743f9594d73e1a1c7730a2e275711543ad78ded1e0e22402f888ef45ab0338d9f3f3d34f08295543f31cebf3930135a0d9068d5aaa642037e5a17765d88e2bf69453eb4e5c9c1ad725327a803f674b41aa4bd77159b876c3798d3033cdb46681892d6bddbba4289729e538a4aea9d437b6f5f66b8b0645424ed8b2715260efafa1173cbbccf2fc0436c4ff9704cd3ebea3b0bcfd40e1fbcd7ea33523b4aec123c635a74dc70a40a7fc6dbab18726b2c78a81e0fbd1e4558b33dd7b888edcd3f2fbab68af5e75ef27f894c554f6bd4411da3c83a9d85397a6d1618e3dd343bac826f9f492eb915875b073713754bfbca28e132caefbaaa6b71f58b5231a1e9e74de414b2b20a37d59b8125c53d98652ba73d885f31d216b948cec0ad896e66bf72d348438734ffb10b31e3b7c9bd817a6176aecd0e3054cfbcaa58cc5983523ba7144fa3c25af250cdfdc10067039c60ecff0a6f08052277f0cfd0766916f71', X'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', NULL, X'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', X'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', X'789c6553cb6e143110fc95fe8065d94459e51c11210e200e89c40171e8d83d33adf831b23db319be866fe1cba8f6262488cb3c3c76557555cd9d8ea912274f775b9c5b8e95f2405f57293e57a10f3c0ca249c8e554176cd09c482b8d92a470081b1519b978f1c4952a0fb2a71befb5e98a332f873551ccb5515d1e6ae3e4a492cfb8a4dc28095eab366e421f6f6f88e7b9e49583e1859c46bbbf252f125921f9a46d02ae5152905502e89bce4b0090a7878dda2458e1b634d3446d9bd501b68f85115fc561fc921738707da096e9e270a038d22c857cd1f4b8a76f930631bcd277a70c112ec728c9e6f6acb0015ee4938d46432e7fc1779dae5bbacc067ed5c1dfc32d6079910880b36bdf8f573fe81e9ae5895da3cfb7c743879a96c81877e5a2720e2a701905945e6628003812495e57f50be6ab92aad9af6d33c217257bfa944fb0a9ecba3102af6277aa1361aa076927914417c7c3ef5f46737996fa38eed102785664cea5d5cee52cad36717b9eaf6775b2dbf1fa7c88265eed4c5d82b120a9811b072893dae3c84feafe0b6347a7ee72452b75004d6ac41eaab14db0c581bf2e6e32a6c66eda1cbaa7bc839d65dada14fb33180b38910fe2476776ddb62afa7381208abc51766e811598fbd509b8f5202f5db8d85f1226bf7fe3558f9129e820efda54044b4951d0ff1a55388de841c91165ea95ba32ac2f9c781453f5cf2f6614cdd0fa178b3c6a30c7462346f3692ee02fd6324d6b0eab9809b3a571fecbcadb74e1b4e3e7cec56c5edabad01f69456592', NULL, 'NCBI', 1768173754, 1768173754, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140506, 19239, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'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', X'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', X'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', NULL, 'NCBI', 1768173756, 1768173756, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140507, 19242, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'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', X'789c6d53cbae13310cfd15ef00a9ad544082ed70592236b04377e1493c1deb66e251e2b41dbe866fe1cb70d2767a85ba9947727c7c7c6c3fe13010477a93614e3c615a60223762e43c810c804e5922703c4a385206d60c6421cede768e9ea2648b87448e66956490083a12f40939eee08bb11fa0171d6140dd02460f27544adb2ca1f481c0c9344ba4a81b7057354098392ce092e46c591b5f10f1dbc60a3da6c4941a1946c58344fe6d380c013e3e1005b9f4bacc8678dbed37d0bdc7fae8378da0fbf06e073f2dc38de95279cd69c03b079b4598945d09984c5ca26cba33d71a06bb77772b4ff842430991f2ead60e7eed3f3ddbe3f333740f5cc344104521f0c44a1e549a82a7ef3fa02f5aaffffe992da5f9641749ca6194a21767c42f3bf8ca46a6ff15b18aeff6b52f0e9367743095ec82b9617c25686bd96c82948f64dfa249667677e5dff8854e9c69f3c8da5709b3f264e6e8b5638982f591aa0e67876e948093c5666bb4444d6c85d5e1b8969a97ac3459de1b8dd830aeb336dc87a3366d28c962d28aad3cb7eaae152c0de8ccabebff0eba8b6147ccad8910e848e1d5d895e8291dc4f4d7a10c74362e1bd5cb12e42ab4099770a7501bdd8dc15c28be8af08fdab0a21fed8bb1ce4926d1264c3cd772ea6e99fad551a0e86d872830067014428bbb391cd9dc742067f626e634b21b57870c8367caff00907872a7', X'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', NULL, 'NCBI', 1768173758, 1768173758, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140508, 19253, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768173761, 1768173761, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140509, 19254, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'789c5d93418ed4301045af524b909a96d8009add0c428805d288e10215a79294b05dc165774f761c82137212be93162076891d7fd7ffffe53ed6c5dabcd0fb872752a7b568e2a271a3c4996719a92e65ffa008bbb7c23908711ee9a2ae96b1bcf0a0512b57bc9e685db8240e166dd680c35278ed621b5908dc8f7084fa2038f9bd69c10d93151ad56b1177cd33e17595e258915c69c1f72d68def5fd4c0f12b8b990b7b0509251c3b1431c2a61a0804385236569c5f0943d69ad024daecb95373f51889a3528b62835afb053f18a7d3951b2acd5ca69f7786440abf54914a2d59ef16555f17d9fc70b061592699250fdd78f9fe2ab40b95bd44c16478114a26ac7525a79b7cc638bd5e9ba187111b20917f4e11396758df2afb1337d942cddd263d11cfab6d353e55229da759f6336723cdfd1270caff041b88e56dfc282086c451308754f2419ae6638dc682c6d868fda5bea5282280e277a111acd8fa2ab2245482276ccd33c6e677a424f515e211c34c4eb5a8cc37247f717d31171c5ed86c17628403f580e86269035f5fa6c229791fb55de87db3b580ccd48013970fd28450d2900948b0acc7de904821118b95103d1aab9ed941ea0090ad9e80d8aa2777415f906a10f630bdd000a56cc7b541790fbacbd3e1ab68e5f68077d7d5879468b15b203929fb48299bf0cfc57fa418a7041bfae339882b51b271bbd7011faca032a7dfd965e9ee9f3c1d73efe84963a8e36f7da90f9105b3734dfe893ca031209fbdfd1cad0ff3da713b041543b38c94a8f3681da3fbc1d70fd757bd5da7fefdf469575a8', NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768173763, 1768173763, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140510, 19256, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'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', X'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', X'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', NULL, 'NCBI', 1768173765, 1768173765, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140511, 19257, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'789c4d524b6edb400cbd0a972da01a6851a017e8c6bba2590659d01a5a623d1a0a2465c7b7e9597ab2be8915200b419466f8f83efcc5a9d23228f9a26da273ddaef6ca8b36a1986dab8566be0ae52cea74aa6685569788cd65a0c9ed963339273e6661cfbde656e8263acd498b354d7329073a2eab7972cb7a1f68acda74546ef13e68bf49673c37f390d619c5865b85abe69d70103a353deb08143a09b8a939571a676e93006a1b67e200815795c4189e34a1d1da402b632071268f9718485bd8d29451b9e3d249fb0ce8b0c8bdd465dd6ae8551a140f04dd59513dbe96ee8554b9eef02087fbac904a6150563122c579ece7f4496295feb7dec101479afad6f9304be163b110e2f2678b5c7a289f877f7ff9c2396b749a5d7a909d11834881370f9fe7fb6a8dd365517ee084f8b6804351bc40506a601e592de2c0df6ac6817ecae8c2210533d65552533ec6562de211fd49a4417a8f4e76a21fb7a4f718d6c3e9e9e9f711c0c73331f25024aaf1b62ca3eb09ad1fbb7ac6d5daf405062db4857477a7adb2bfaf41cf1e5a773a7dcabe6d0075196d814505a86924adaf234186dbea7055a874d5b6761b0ff4fcf5c70b3d7ffbfef21fec0b188b', X'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', X'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', NULL, 'NCBI', 1768173768, 1768173768, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140512, 19284, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'789c4d534b8ed43010bd4a69d64d034282f5088406891d880d6251b12b7169fc09fea495dbcc59e6643c3bd3f46ca2d8aa57f53ee5fb8dd5f3e485bea4c28bd0d79443218e967ed42c71a9aed0679e67d128a485d25459e340cc3905da386b6a854a6ad948399146e39bd5b8904980094dc211f7860da7ebe13179a6d82a7eab3079e1ad6377c91353e02aa741a13aa1a571e6c840e6bc9fe95b24b656aba6d87bde889914428a7ea7393540b98b7829dd5010c1d0f2a14ca2e465279b353e425106369616c4f6b2355dace47e5bbbca8a7e399ce9f7a73f743f9594d73e1a1c7730a2e275711543ad78ded1e0e22402f888ef45ab0338d9f3f3d34f08295543f31cebf3930135a0d9068d5aaa642037e5a17765d88e2bf69453eb4e5c9c1ad725327a803f674b41aa4bd77159b876c3798d3033cdb46681892d6bddbba4289729e538a4aea9d437b6f5f66b8b0645424ed8b2715260efafa1173cbbccf2fc0436c4ff9704cd3ebea3b0bcfd40e1fbcd7ea33523b4aec123c635a74dc70a40a7fc6dbab18726b2c78a81e0fbd1e4558b33dd7b888edcd3f2fbab68af5e75ef27f894c554f6bd4411da3c83a9d85397a6d1618e3dd343bac826f9f492eb915875b073713754bfbca28e132caefbaaa6b71f58b5231a1e9e74de414b2b20a37d59b8125c53d98652ba73d885f31d216b948cec0ad896e66bf72d348438734ffb10b31e3b7c9bd817a6176aecd0e3054cfbcaa58cc5983523ba7144fa3c25af250cdfdc10067039c60ecff0a6f08052277f0cfd0766916f71', X'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', NULL, X'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', X'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', X'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', NULL, 'NCBI', 1768173770, 1768173770, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140513, 19284, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768173772, 1768173772, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140514, 19285, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'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', X'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', X'789c6553cb6e143110fc95fe8065d94459e51c11210e200e89c40171e8d83d33adf831b23db319be866fe1cba8f6262488cb3c3c76557555cd9d8ea912274f775b9c5b8e95f2405f57293e57a10f3c0ca249c8e554176cd09c482b8d92a470081b1519b978f1c4952a0fb2a71befb5e98a332f873551ccb5515d1e6ae3e4a492cfb8a4dc28095eab366e421f6f6f88e7b9e49583e1859c46bbbf252f125921f9a46d02ae5152905502e89bce4b0090a7878dda2458e1b634d3446d9bd501b68f85115fc561fc921738707da096e9e270a038d22c857cd1f4b8a76f930631bcd277a70c112ec728c9e6f6acb0015ee4938d46432e7fc1779dae5bbacc067ed5c1dfc32d6079910880b36bdf8f573fe81e9ae5895da3cfb7c743879a96c81877e5a2720e2a701905945e6628003812495e57f50be6ab92aad9af6d33c217257bfa944fb0a9ecba3102af6277aa1361aa076927914417c7c3ef5f46737996fa38eed102785664cea5d5cee52cad36717b9eaf6775b2dbf1fa7c88265eed4c5d82b120a9811b072893dae3c84feafe0b6347a7ee72452b75004d6ac41eaab14db0c581bf2e6e32a6c66eda1cbaa7bc839d65dada14fb33180b38910fe2476776ddb62afa7381208abc51766e811598fbd509b8f5202f5db8d85f1226bf7fe3558f9129e820efda54044b4951d0ff1a55388de841c91165ea95ba32ac2f9c781453f5cf2f6614cdd0fa178b3c6a30c7462346f3692ee02fd6324d6b0eab9809b3a571fecbcadb74e1b4e3e7cec56c5edabad01f69456592', NULL, 'NCBI', 1768173774, 1768173774, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140515, 19288, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'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', X'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', X'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', NULL, 'NCBI', 1768173776, 1768173776, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140516, 19314, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768173779, 1768173779, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140517, 19315, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768173781, 1768173781, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140518, 19328, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'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', X'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', X'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', NULL, 'NCBI', 1768173783, 1768173783, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140519, 19337, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768173785, 1768173785, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140520, 19337, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768173788, 1768173788, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140521, 19338, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768173791, 1768173791, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140522, 19338, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768173793, 1768173793, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140523, 19343, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'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', X'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', X'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', NULL, 'NCBI', 1768173795, 1768173795, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140524, 19345, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768173797, 1768173797, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140525, 19359, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'789c6d53cb6edc300cfc155e8a36c0360850ec17b43df4905b6e450f5c89b689ca922b4ace6ebebe433b29b24d005f2493c379500f93509ba4f222bd6920cd51cef4e9e1c70d99d4558c185ff67b0ddc4aa5321053ac7dfc68643c48bbd052cba0490e288ca4468153e8899b443a5d289479e1aa79f441148b0955f9d3b5e2772b8edc034894b3060598663ade7dd8c72c65711c2d1994be1def6ee851dbf482c3a373e746179514ed4a870c838466afd0bce935de77c7bba5870984abdfb98c552324af9c3a9f92a0db749c361830ddc6eec267ae23a001bb5be03842138adf71135533d40da99c39a04be725a9d8cedd4177b2ba5e47b1390572a0907580fbb9a50ba5f228d55bf3b3a226b92927fcda2cdcda9e65758caf164af518e9540bc737cc6928f56a2c2f60173693ec96eeaf881b8d9251ead31e25a5cfad241c3d6848b186fcb9c6372aecb0e7c671059fdd44ec00876d089d042be2fb3183a9a78003446ddb64821671743717ca37bc5bfaf9e5f88bbe967946942fb02f99ff578c1442ea5168646bb5204ab1a699d3bf06eb61f23dcfdc4df8402b18a0623c5054ae75f23b27c3a7e8dcd0b9b0e60305b08419044bd6d28173b126f31b58f4470e9338dcd313b499ed78a1e4a11b3c38d0dc0d4fa6d86f49d2dea1869463c96065e4796d27aa7d69bd0217ef0b5e63b56bda1e5049081eb74dc1d0df6ffc0bb9a36f31', X'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', X'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', NULL, 'NCBI', 1768173800, 1768173800, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140526, 19361, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'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', X'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', X'789c6d933d8edb400c46afc22e8dd740825c6091262982145b0629a8195a223c7f98a1ec28a7f1597cb27c23add7de20a5a419f27d8fd48b8ea911274f2f4b2c9663a37ca01f27a93e37a12f9c780c7a08f98f26cab7d7fdbce5dfead416729c4893abc2f8629350d576ec55a6a5e4312c4ea2329d2749c43e6ad26652c5d3596da28c0b95bcf220a68ea278756c9a53dbd3b70331153c49329ab8511300c8bbbabbde71a136e539781c0887a77b13709244a9a324b7d01866c7634e7454dbd3b3f7dafb70a0f690fc2d221285d9cbada79769f17525db9104715673580ce7e2c0819393b65bb538a01b0338e4330d21674fa54a6b73953d7def3a4184cf8f967bd007bb8aa4732be8217e476afd85abb353b05a06911cd1b6ab62006cca02b119ea82ef8661ecec217e937a5260a2b69b0836fba84ad6861bfd34f2904305a9fb3b9961aab6f2da527a9bb0ac09a177d5d5e65272353d09d6009a8057bb305cfdbfa46dea8730abc7c912d86d3a3a333f8ce45e3762af20aff5da71f5f736b03dfdfcf8e917f45d2f2e60e6308465f622b15b4b827e8debb25145f8a539f1d0721db07ebece23b2c4921300d634ee71db314efafc84bdaa34e1326487a5f5d1a068b7dcd7feb5eabb7bbd5b123c8e3a04a1001d01a45f85834d9b24612cdbebca6a2c6153b04540f898935aae9a461af04f79cae97a59a7b5fd0b1f1a887ab5eb05ab6633aa3fb77f20003ae938615ca56613bc297f018f4079f9', NULL, 'NCBI', 1768173802, 1768173802, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140527, 19362, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'789c8553bd8e1331107e956910204591a8aea1a1414741051da298b567ed115ecfe2b113f69ee69ee59e8cb193ec9d400829cdda9e6fbebf7c96cc550ae7002b165ca8525198a50067cf27f60d93c244fd412d84953c9cb946709831249e933c7086baadec30a5cdc64e924e04084e96893356960c3243c2490adaae0d2a69ed80983db8c4b98f02aa92ea42b92a5401cada0ac142de6e0706cd33b9ca27caf66ecc2ace54b7237cedc4fa2484c69e0c9114bc40960a6b115341a02b399ed9412123668ffd405530e41a09e6423f1b65b78169f7adecbc97dd215b1449e9a5511aa5256ffe3c3d3efbc50f6652b790d0c5a7c7d5a03ab709d5ce0d142112a61a1d9a40e3379b1e5b86e9b53edbe1595da14ee2085f383bfac371ee16d8af72dc562a216d8e169387a1efeaeee0f04b4db0414348cd8991c749a5ac1df7f02f1abbac42a1252c96aa8be47ec05589d1f48c93396049c5222dc4db539892881f012bbcb97c680b7691e844e912dbfdf4e19d7b7bb8129b5b76173afd8e7cb3b8e9b66ac4833ed268a8d5028d2999333c99979ec9a426c9417bc4e82dc23e4cbfa838563ac2fd7f145ec3bd50827a66d79bbb9111ee01ee2cce5120a2d55a2b4e8960b7db49ae45d2c5f0d157aafb7f6554d29a06416ce7113ecd2fcec7d998e935b53e1dae2cf64eddd89952d355ac70c9cafeedee3b7c346e59b2591132f6b87d4b550fa3c81df72fa4f777af7e03551d75cd', X'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', X'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', NULL, 'NCBI', 1768173804, 1768173804, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140528, 19371, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768173806, 1768173806, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140529, 19372, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768173808, 1768173808, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140530, 19375, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'789cad53cd6e1331107e9579804d480a51256e11a852251095405c1007ef7ab23bc53fc163a7d9b7c9b3e4c998f1a6695aca8d4be4597bbebf99ac77869c691dc2c7c8a647b889c9339860e16b4e18fa3c307cc04d49714f1e81e4eedc42017626512c0c1b692bce648a811bb9e85cb1147a88c938c8fa3acbf75a71e12d0696974de5d9c6078b4911a4ef1ebb8a31876f035e7643f724c2ec3193fb4b0b9f05c70d5cad16e0fb4ab05ae8f102f1498120247c8ed2c5d061c869f2a250cbab95f4bf919f4f156f82aef504fa9a839a884ae4b2dd3a425bd322e35819b2a1a0f15c57a80696f315f4531cd77a54da4bc37c5971b454fc1cd6d60b0a9fa46a4bfe9798ce0468116c0c0848f22ca916b8fd2c81c0ed7748b16454c4e2f2e326bc98fa890c9358c90fd46996c7431e921ead0438366051729de61eaa18c61d26cae3a3380a9b49d11c7ebc7df7b3a677da8e6afec57804d0cb10d421428861d652c4df8576c6a14ca9016f7e299b40fb7acfa5e54cb9544c1561c09373d427e36739cece05b48649b6ec6e30690c3d65b128516461d32752be5771c743c22e7a2faec4b69d82793e1b693ceddadd1750bba32c0c0cb1a4faaf381e960b896714ae7527210b712721ca2288f8bd70093f3085c2ff91145ee5fc03d2be6914', X'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', NULL, X'789c65504b4e03310cbd8a0f005df40a5d7302d44548dc89c1638f6ca7309c1e07844688451459eff97d7cc1db30fda015a1b495843cac04a94091064d9d6401c18aee142526eb7578ac280124101d6141a312461536dd061fdb248deed4466187778a9eb81a184a61b80da993788227150ab5e9f3170272a8362a157e80ad58504d75e37d1a57a39c0bcf8939e1a08ce42951314d53acd3d2d16605f4ef38ca2de75fe6092e9c75535d1cbcebe006195461fdc9039b6974d3f565d69cf7c9bfc4a391bf1d765397e99eba289ffb9a4ec9fad7bbe35ca8d0763f7a3f9faff9ced72f0ba09156', X'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', X'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', NULL, 'NCBI', 1768173811, 1768173811, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140531, 19377, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'789c75535b6e143110bc4a1f60b302c4051012023e097f281fbd7667a7c1768fba3d9b4c4ec319380207e04c946713b111cacf6a3d7257753d7cad550b3b75a3599a262d455b10b74cd5a2d39f5f578553e78a4f5d0f6a5d53ec28c9ede276af5548838ed2c4b99495eea494ab6e05c72e794f1fed4e4ee2cf062aaf345b17e06d3345380f7eceb81942d99723b980550dab68a3308ccddc153320e7a0106974a77d22eb933855c99a781bd8d3d749cecb27abd51a285c66732cf41207bbd091a3bb69eb125d1b17ca1a7df103b72420d596ca92b51da9f112c23b3a5955dc3cee36b7b2b2fb24bca76f6fdedcd0bb9c756003e73fe017850e06019ab9dc2b18f890c1314666d6b603c7c38336893853822d739a644f9f1a250e09b25b5c75d834f2f8fd9333c621c3376b76542c01ec427727d807e6efb27da1d02e975afbe4560f364f450ed03392e74696d2e27b7aff3c5329a84fa7699d87ba06283d695fffd15d02cfbef8197071548a7dd30b51f103813bc724b1e9f2910d2ad91f7388d127b9048d254da313dc789ed6c2f70375f3f6f6dc3df1152a2b535d4ad75bf30a8d1d8b279259b37885294d925b59431fcdbdee186e71f5d9a616c399b5657881c9894f428751c0a75a21f3b7af6ee8cb761c416e6544c0c014e432a2aa762c768036f371e26e090660390b6d3058cb930333f6b07694eddf39008cf561334758d2f1b4cee5bf7855e8e458e3f50d7ed0bf0fb0150fa3a24ae02872e2bfb29475ea', NULL, X'789c65504b4e03310cbd8a0f005df40a5d7302d44548dc89c1638f6ca7309c1e07844688451459eff97d7cc1db30fda015a1b495843cac04a94091064d9d6401c18aee142526eb7578ac280124101d6141a312461536dd061fdb248deed4466187778a9eb81a184a61b80da993788227150ab5e9f3170272a8362a157e80ad58504d75e37d1a57a39c0bcf8939e1a08ce42951314d53acd3d2d16605f4ef38ca2de75fe6092e9c75535d1cbcebe006195461fdc9039b6974d3f565d69cf7c9bfc4a391bf1d765397e99eba289ffb9a4ec9fad7bbe35ca8d0763f7a3f9faff9ced72f0ba09156', X'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', X'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', NULL, 'NCBI', 1768173813, 1768173813, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140532, 19378, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'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', X'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', X'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', NULL, 'NCBI', 1768173815, 1768173815, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140533, 19379, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'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', X'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', X'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', NULL, 'NCBI', 1768173817, 1768173817, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140534, 19409, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768173819, 1768173819, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140535, 19409, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'789c75534b4e1c3110bd4a2d136940249b90652284823491582036110bb75ddd6dc9ed6aca36d1e4349c8593e5951b9851a4acfae3fabc9f6faef6b43aadd1272ee49469145d38509d55da34e3c9b4bfdd9fe15f741507ca8b3cb9443252d538a583678d01cda3ca42f7fbabfd39fde0d56124a5b8bac254da50f8b171aee9405ef2136b2d361967c7e555a837dfcdadece806c09457454d46b1cbc4c55e23565775b9c41a2553a90085d340812beb123397976703ed67c154fc9344899f381583eca3fa96002e4fb6edb8fe9c7e5d3e74f8540ed9b0453478dfb450cc2fcf9fb18a57945d472d75d77529de8da3a440ab4ae598e9db2adf3f5d5c50cb81751290eaf301194ac4e03ae4e1404bf42a4596cee5a8e1466c647d1ff8e1e7dded470a4d0d6f3f4ddb1063dcbf57d16ad2199ecd31ce41d6e40a964041b06ba92dbbeeab4d81a467f7ff50df1fd181b597654d6c5eff9e391f1b869843b7e914f399463f9fb8d853d0c55944ea7fd098c966fe6b2a4ca0ae6e0f609d8d46273580134fe617c040373fbb1586667e13084189d9a71636669b6821969646d3334263568ba0e935a5e6a500f1fbc8b78e2f97b0ffeb03dde437eea78621832d558b01b5213e36242f1f4e7c083ca97bad45c4a097a546f4a8ca8e5c01598889196ee0ea305e5eb7f312ddeee5d9d9cd085baac1539d4776e39f4e7c4b7492d2333cb6ecad0caa211e3be00bcdf780a0c8e1962c03ee190abb6b86d0cf8724cb5fff5675dc', NULL, NULL, 'NCBI', 1768173822, 1768173822, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140536, 19410, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768173824, 1768173824, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140537, 19410, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'789c75534b4e1c3110bd4a2d136940249b90652284823491582036110bb75ddd6dc9ed6aca36d1e4349c8593e5951b9851a4acfae3fabc9f6faef6b43aadd1272ee49469145d38509d55da34e3c9b4bfdd9fe15f741507ca8b3cb9443252d538a583678d01cda3ca42f7fbabfd39fde0d56124a5b8bac254da50f8b171aee9405ef2136b2d361967c7e555a837dfcdadece806c09457454d46b1cbc4c55e23565775b9c41a2553a90085d340812beb123397976703ed67c154fc9344899f381583eca3fa96002e4fb6edb8fe9c7e5d3e74f8540ed9b0453478dfb450cc2fcf9fb18a57945d472d75d77529de8da3a440ab4ae598e9db2adf3f5d5c50cb81751290eaf301194ac4e03ae4e1404bf42a4596cee5a8e1466c647d1ff8e1e7dded470a4d0d6f3f4ddb1063dcbf57d16ad2199ecd31ce41d6e40a964041b06ba92dbbeeab4d81a467f7ff50df1fd181b597654d6c5eff9e391f1b869843b7e914f399463f9fb8d853d0c55944ea7fd098c966fe6b2a4ca0ae6e0f609d8d46273580134fe617c040373fbb1586667e13084189d9a71636669b6821969646d3334263568ba0e935a5e6a500f1fbc8b78e2f97b0ffeb03dde437eea78621832d558b01b5213e36242f1f4e7c083ca97bad45c4a097a546f4a8ca8e5c01598889196ee0ea305e5eb7f312ddeee5d9d9cd085baac1539d4776e39f4e7c4b7492d2333cb6ecad0caa211e3be00bcdf780a0c8e1962c03ee190abb6b86d0cf8724cb5fff5675dc', NULL, NULL, 'NCBI', 1768173826, 1768173826, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140538, 19424, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'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', X'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', X'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', NULL, 'NCBI', 1768173828, 1768173828, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140539, 19425, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'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', X'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', X'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', NULL, 'NCBI', 1768173830, 1768173830, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140540, 19426, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'789c8553db8ed33010fd95f980b6e2222eeac34a5501890784b43ca23e4ced4933d471227bdc6efa357c0b5fc671d2057661c58b93898fe75c3cd9068dea3884916e25c889a3d1c69f2465a1f74d23ce326d7f63b21ea2362800e32b4caeb0bea1d4e772e26c6c1a49a30bc50b592bd4f421f4678d87356d93d46d8d42478d8c063878f3fc19997692277419064914b453ab9bb14f1d07fa22e013eac67e606ba1b7e5bdef5186316ba64d1e388159883b8dbd258eb991341124e2c013e55f7b9369d33e4e066e5efe5fc6e46ea9d117279ed815ab4e7c941196bf9534d2d717af76585ed7e5cd8e6e19b21fa7759f4e94f312e462e495f762e0ee2404b59217d44ac75692f28286d49b689c0b8e9eda71a80d6356d393da48c8d54d4656a07dbba3cff090f075e89355a14f0868853dbb56161070b920a30ce2c8250b881cda990e53400b1c31b430102207374e6f0023f6367138dc2b3b0b1f6b9b15bd4be5b0ac0b7dac47affae893788cd0fc6e2d1b755cb3737090e779499a8f35f35f977d6e25420d7bdc9f66f482a3b35afb60e4d63fbe7fd07dc20ce42a3db8561d0cc1190f864941b1a0a664053d2e4e3d8c2a4f5fe727a6c3030e332687c4274d28c03442984194437c77567dcc4e53813af6e058fddb94973f4c6549a5ab913a896852a18f7f9a356da2556535d68143b1ab24097ce883decdbc9203b8d29e2f323c4dfe20d19f8d177403', NULL, X'789c6d933d8edb400c85afc22e8ded20409022a90ca7c8022eb70b528c469444786628cc8fbdbacd9e654f96476917dec2850d8933241fbf473d4f4c8386a0374923454d5235dbe3ecb28b5c39177299a973857bd2441509c7d3e9ebf1cff14b213f69e0825b1a686cd27390c494d96b8c9c7a574553f949a7cc78c4c93c69c1ef2209f528f09543a132690b3d25add421599b5d0d0b4576a565ee7fd1a4375ccdbbb7d7f7188a57d2e1edd53faefc5e12e53c044017ca9024f2382c74933a91a319c369728134d3e0a2a0e52405f32f284da55a6124558c985df2bca33eb7716f7f1646d0aff38189ab889816f4364259cac58ac4456757a765673d5ae2973938a8ed29b6e20354e3cd8e6eec2e894b39d05930280d2dadb5a9822eecd859f9d07a73c6157803714cd00c68d05606882910e8824b46e3d1c9c5853b2857b768eaa96a05834e82e4d641cee60a8655a0325312b3dd329a1f96dc5d3ad0d34013634af1241103e5cd9c4c658973d50883db38da1c5736262dc18eb0d8286b9e567d112f15d4bd6f99fab62e20306637835c784884a25b4c51c78907a4bb70a0bfdf7efc03c0597a8085b847f4cebfcffbd30e468fd3be67ec06fa069975ce5a59d28e6a96312c9e33b6a67c26f479d73f18ddf74cbbba397b978fae52218cae82364610e9ae0b526cfbec8b5a0d196cfd5a05d6cfdfdfdad796db681ee81934d80de80e49d8d68d41d866cd3a48e047626cd361e97734ff0fd0cc7720', X'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', X'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', NULL, 'NCBI', 1768173832, 1768173832, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140541, 19459, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768173835, 1768173835, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140542, 19483, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'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', X'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', X'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', NULL, 'NCBI', 1768173837, 1768173837, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140543, 19503, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'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', X'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', X'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', NULL, 'NCBI', 1768173839, 1768173839, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140544, 19525, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'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', X'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', X'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', NULL, 'NCBI', 1768173841, 1768173841, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140545, 19549, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768173844, 1768173844, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140546, 19552, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768173846, 1768173846, NULL, NULL, NULL, NULL, NULL, NULL, NULL);